June 26, 2017 4:29 AM ET

Biotechnology

Company Overview of Adaptive Therapeutics, Inc.

Key Executives for Adaptive Therapeutics, Inc.

NameBoard RelationshipsTitleAge
Diego Miralles 33 RelationshipsPresident--
M. Reza Ghadiri Ph.D. 28 RelationshipsFounder and Chairman of Scientific Advisory Board--
Max Ladjevardi 11 RelationshipsFounder, Chief Operating Officer and Director--
Muzammil M. Mansuri Ph.D.33 RelationshipsExecutive Chairman62
Daniel L. Kisner M.D.78 RelationshipsConsultant and Director69

Adaptive Therapeutics, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Muzammil M. Mansuri Ph.D. 33 RelationshipsSanofi62
M. Reza Ghadiri Ph.D. 28 RelationshipsAdaptive Therapeutics, Inc.--
Max Ladjevardi 11 RelationshipsAdaptive Therapeutics, Inc.--
Daniel L. Kisner M.D. 78 RelationshipsAdaptive Therapeutics, Inc.69
John Warren Kozarich Ph.D. 65 RelationshipsCorium International, Inc.67
View All Board Members

Adaptive Therapeutics, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board Ph.D. M. Reza Ghadiri28 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
390.2K
Bonus
246.7K
Total Short Term Compensation
486.3K
Total Value of Options
18.2M
Compensation as of Fiscal Year
Adaptive Therapeutics, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

IsoRay, Inc Announces the Resignation of Matthew P. Branson as Controller, Principal Financial and Accounting Officer
June 23, 2017 9:15 PM ET
AngioSoma, Inc. Announces Executive Changes
June 23, 2017 5:46 PM ET
Protagenic Therapeutics, Inc. Announces Resignation of Gregory K. Ekizian as Director and Chairman of the Audit Committee
June 23, 2017 3:21 PM ET
VBL Therapeutics Appoints Corinne Epperly as U.S. Chief Operating Officer
June 22, 2017 8:34 PM ET
Biohaven Pharmaceutical Holding Company Ltd. and Biohaven Pharmaceuticals, Inc. Announce Executive Appointments
June 22, 2017 7:00 AM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Adaptive Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.